What is iRadimed's market cap?

iRadimed (IRMD) has a market capitalization of $1.2B and trades on NASDAQ.

What is iRadimed's revenue and profitability?

iRadimed generated $86.3M in trailing twelve-month revenue with net income of $23.6M, representing a net margin of 27.4%. Gross margin stands at 76.8%, with free cash flow of $24.5M. These figures are based on the Q1 2026 filing.

Who are iRadimed's competitors?

iRadimed's key competitors include Koninklijke Philips NV, GE Healthcare Technologies, Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.

Who does iRadimed partner with?

iRadimed's notable partners include Masimo.

Where is iRadimed headquartered?

iRadimed is headquartered in United States of America and employs approximately 148 people. It has been publicly traded since 2014.

iRadimed

IRMD

Market cap

$1.22B+63.8%

Revenue$86.3M+14.8%

Net income$23.6M+19.3%

Free cash flow$24.5M+67.6%

EPS (diluted)$1.83+18.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 1, 2026

Revenue$22.0MBeat by $664.0K EPS$0.49Beat by $0.03

Read the full report

Next report

Jul 31, 2026 (In 2 days)

Revenue estimate$20.4M

EPS estimate$0.42

Financials

Q1 2026

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation & ratios

Valuation

See full

Market cap$1.22B+63.8%

P/E51.5×+16.3×

P/S14.1×+4.7×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Current ratio7.1×-1.7×

Segments

By product

See full

MRI Compatible IV Infusion Pumps$7.7M+27.8%

MRI Compatible Patient Vital Signs Monitoring Systems$7.1M+8.6%

Disposables$4.9M—

Services and other$1.0M—

Amortization of extended maintenance agreements$659.0K—

Competitors

By market cap

GE HealthCare Technologies$27.8B-21.9%

Philips$24.3B+2.4%

Merit Medical Systems$4.5B-9.1%

ICU Medical$4.0B+28.6%

iRadimed$1.2B+67.4%

InfuSystem Holdings$188.9M+52.6%

Stereotaxis$129.5M-44.6%

OneMedNet$34.5M+49.7%

By revenue growth

iRadimed+14.8%

Stereotaxis+13.4%

Merit Medical Systems+11.1%

GE HealthCare Technologies+6.5%

InfuSystem Holdings+3.5%

ICU Medical-10.9%

By net margin

iRadimed27.36%+1.0pp

GE HealthCare Technologies9.33%-1.9pp

Merit Medical Systems9.03%+0.2pp

InfuSystem Holdings5.56%+3.2pp

ICU Medical-0.317%+7.0pp

Stereotaxis-69.5%+22.7pp

Profile

iRadimed Corporation develops, manufactures, and distributes specialized medical devices designed to operate safely within the high-strength magnetic fields of Magnetic Resonance Imaging (MRI) environments. The company's core value proposition centers on providing non-magnetic infusion pumps and patient monitoring systems that eliminate the safety risks and technical interference associated with standard medical equipment. Their solutions enable continuous critical care and vital signs monitoring for sedated or critically ill patients during MRI procedures.

Competitive position

iRadimed holds a unique market position as the only known provider of non-magnetic IV infusion pumps and competes as a specialized alternative to larger, general-purpose medical device conglomerates.

GeographiesUnited States, Europe, Asia

Customer segmentsHealthcare Providers, Hospitals

Business modelManufacturing, Razor-and-blade, Direct-to-hospital

SuppliersElectronic component manufacturers, Non-ferrous material suppliers, Specialized battery manufacturers, Contract sub-assembly providers

CustomersHospital radiology departments, Intensive Care Units (ICU), Emergency Rooms (ER), Outpatient imaging centers

CountryUnited States of America

Listed2014

Employees148.0

CEORoger E. Susi

SectorHealthcare

IndustryMedical - Devices

Websiteiradimed.com

FilingsSEC EDGAR

Ask your AI about iRadimed.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's market cap?: iRadimed (IRMD) has a market capitalization of $1.2B and trades on NASDAQ.
What is iRadimed's revenue and profitability?: iRadimed generated $86.3M in trailing twelve-month revenue with net income of $23.6M, representing a net margin of 27.4%. Gross margin stands at 76.8%, with free cash flow of $24.5M. These figures are based on the Q1 2026 filing.
Who are iRadimed's competitors?: iRadimed's key competitors include Koninklijke Philips NV, GE Healthcare Technologies, Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.
Who does iRadimed partner with?: iRadimed's notable partners include Masimo.
Where is iRadimed headquartered?: iRadimed is headquartered in United States of America and employs approximately 148 people. It has been publicly traded since 2014.